443 related articles for article (PubMed ID: 19954275)
1. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine XR: current status for the treatment of major depressive disorder.
Pae CU; Sohi MS; Seo HJ; Serretti A; Patkar AA; Steffens DC; Masand PS
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1165-73. PubMed ID: 20307622
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
4. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
Adler CM; Fleck DE; Brecher M; Strakowski SM
J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
[TBL] [Abstract][Full Text] [Related]
8. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
Sheehan DV; Locklear J; Svedsäter H; Datto C
Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
[TBL] [Abstract][Full Text] [Related]
9. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
[TBL] [Abstract][Full Text] [Related]
10. Bipolar depression: a new role for atypical antipsychotics?
Keck PE
Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
[TBL] [Abstract][Full Text] [Related]
11. The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder.
Weisler R; McIntyre RS
Expert Rev Neurother; 2013 Nov; 13(11):1161-82. PubMed ID: 24175720
[TBL] [Abstract][Full Text] [Related]
12. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
13. The role of quetiapine extended release in the treatment of bipolar depression.
Cristancho MA; Thase ME
Adv Ther; 2010 Nov; 27(11):774-84. PubMed ID: 20835785
[TBL] [Abstract][Full Text] [Related]
14. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
15. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
Gabriel A
Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine: a review of its use in the management of bipolar depression.
Sanford M; Keating GM
CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.
Vieta E; Bauer M; Montgomery S; McIntyre RS; Szamosi J; Earley WR; Eriksson H
J Affect Disord; 2013 Sep; 150(2):639-43. PubMed ID: 23497790
[TBL] [Abstract][Full Text] [Related]
19. Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.
Clayton AH; Locklear JC; Svedsäter H; McIntyre RS
CNS Spectr; 2014 Apr; 19(2):182-96. PubMed ID: 24067192
[TBL] [Abstract][Full Text] [Related]
20. Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.
Weisler R; McIntyre RS; Bauer M
Expert Rev Neurother; 2013 Nov; 13(11):1183-200. PubMed ID: 24175721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
